So How Can I, Pretend that I Don't Know...

what's going on...when every minute...every second, another soul is suffering!

Dr. Meena Augustus, and Cia, my Guardian are joined in an effort to bring a revolutionary technology, the Cytotron, to those suffering in the US. It is a non-invasive procedure, with no side effects that ameliorates tumors, and lesions.

Help us make, needless use of chemo and radiation, which often causes waste, pain, suffering and death itself, be a thing of the past. Cia's & Silka's role is a humanitarian one, whereby their experience you are likely to benefit, if you ACT, b/c Two out of Five Americans, will succumb to cancer.

European countries like Switzerland & Kosovo, has adopted its successful use for brain cancer for young and old, and a host of other ailments that require tissue regeneration. In India, health care insurance pays for this successful treatment.

We should be outraged, that such technology exists, but only for the wealthy in US, who can avail themselves of medical tourism. We CAN, CHANGE THAT!

Our goal is to bring into the states, NEAR US, the Cytotron-->PLEASE JOIN US, in INVESTING in our future and of all our loved ones, of every kind (human and veternarian).

About Dr. Meena Augustus:
MEENA AUGUSTUS, PH.D. Executive Partner - HealthCare Global Enterprises Ltd. & Triesta Sciences Inc. (India), Co-Founder & Chief Scientific Officer, Shréis-Scalene Sciences Inc. USA.
Dr. Augustus was co-founder of Avalon Pharmaceuticals Inc., a biotech company using cutting-edge, revolutionary drug and target discovery approaches in cancer. As Senior Scientific Director, she oversaw the efforts of the Molecular Genetics and Oncology group since the company's inception in 2000 to November 2002, and was instrumental to the development of Avalon's Amplicon and Biorepository databases. She developed Strategic Scientific Alliances for Avalon between 2003-2006, initiating and establishing several key scientific, academic and clinical collaborations for the company, both domestic and international.
Currently, Dr. Augustus' company Shreis-Scalene is focused on bringing to the US and global markets, two portfolio medical devices: a diagnostic device the HemoseisT for the detection of cardiovascular diseases; and the Cytotron T, a therapeutic device that uses rotational field quantum magnetic resonance (RFQMR) in the treatment of diseases like osteoarthritis, cancer and more.

Dr. Augustus has served in premier research institutions in India, Germany, France and the US, and has been the recipient of the prestigious German Academic Exchange Service and Alexander von Humboldt Fellowships to pursue the study of cancer genetics and clinical oncology. She spent 18 years as a member of the oncology faculty in a UICC-affiliated, 250-bed Comprehensive Cancer Research, Treatment and Teaching Hospital in Bangalore, India, eventually serving as Professor and Head, Department of Cell-biology & Pathology. She played a key role in a large scale WHO-sponsored cancer detection and screening program in Karnataka, India, and was a co-investigator in a multi-institutional Indo-US (NCI-sponsored) study on the molecular characterization of lymphoid neoplasia.
Dr. Augustus worked as a Special Volunteer with the Fogarty International Center, NIH and has held a visiting scientist position at Human Genome Sciences Inc., where she mapped more than 100 new human genes to their chromosomal locations. She also served as a consultant at the Center for Prostate Disease Research (USUHS/Henry M. Jackson Foundation for the Advancement of Military Medicine), where she pioneered a study on the molecular cytogenetic analysis of prostate cancer.
During 1997-1999, Dr. Augustus was a visiting scientist in the Lymphoma Biology Section-Pediatric Branch and the Cancer Genetics Group (NCI/NIH), and the Genome Technology Branch (NHGRI-NIH) in Bethesda, MD. She played a key role in the design and development of the recently launched NCI and NCBI SKY/CGH Interactive Online (Cytogenetic) Database, a public resource that will enable the compilation and analysis of chromosome aberrations in cancer, both human and mouse.
Dr. Augustus earned an MS in Zoology in 1974, and a Ph.D. in Human Genetics in 1979, from India. She has published widely---original articles in peer reviewed journals, text book chapters and has presented invited talks in key industrial forums.

Pasted from <http://www.bioitcoalition.org/events.annual08_Bios.html>

PLEASE Grant my Wish

AND I BELIEVE .... I WILL SEE....SOME END TO HOPELESS, OF GIVING UP AND SUFFERING.

IF WE ALL STAND TOGETHER AS ONE, NO ONE WILL BE LEFT BEHIND-STAND UP & JOIN US!

Travel with your Dog, in cabin (no size limit). A Member Based, Full Service Travel Company for Dog Lovers Watch the Dogtravel Video

PLEASE COMMENT FOR SUGGESTIONS